Promoting predictive, preventive and personalized medicine in treatment of cardiovascular diseases

Affiliations

¹ Professor of Public Health, Department of Social and Environmental Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadagaoka, Suita-shi, Osaka, 565-0871 Japan.

Hiroyasu Iso. EPMA J. 2011 Mar.

. 2011 Mar;2(1):1-4.

doi: 10.1007/s13167-011-0075-0. Epub 2011 Apr 7.

¹ Professor of Public Health, Department of Social and Environmental Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadagaoka, Suita-shi, Osaka, 565-0871 Japan.

No abstract available

Figures

1. Rosolova H, Nussbaumerova B. Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases. EPMA J. 2011 - PMC - PubMed
1. Colley KJ, Wolfert RL, Cobble ME. Lipoprotein associated phospholipase A2: role in atherosclerosis and utility as a biomarker for cardiovascular risk. EPMA J. 2011 - PMC - PubMed
1. Miura K. Epidemiology and prevention of hypertension in Japanese: how could Japan get longevity? EPMA J. 2011 - PMC - PubMed
1. Yatsuya H, Yamagishi Y, Iso H. Adiposity and risk of cardiovascular diseases in Japan: secular trend, individual level associations and causal pathway – implications for the prevention of cardiovascular diseases in societies with rapid economic development. EPMA J. 2011 - PMC - PubMed
1. Kokubo Y. Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment? EPMA J. 2011 - PMC - PubMed